CDC launches antibiotic stewardship toolkit for healthcare payers
The Centers for Disease Control and Prevention (CDC) yesterday launched a toolkit to help healthcare payers support appropriate antibiotic use in outpatient settings.
The toolkit, developed in collaboration with the Pew Charitable Trusts and healthcare stakeholders and based on the CDC’s Core Elements of Outpatient Antibiotic Use, identifies the activities that healthcare payers can implement to support outpatient antibiotic stewardship in primary care clinics and urgent care centers. Those activities include tracking and reporting antibiotic use within insurance networks, communicating commitment to stewardship to network members, implementing patient education campaigns, ensuring clinicians have access to current clinical guidelines, and conducting audit-and-feedback interventions for high-prescribing clinicians.
The CDC says healthcare payers—which include private health plans and Medicare and Medicaid—can play an important role in improving outpatient antibiotic use, because they have financial oversight in the provision of healthcare and are uniquely positioned to facilitate quality improvement measures.
Among the examples provided in the toolkit is an audit-and-feedback intervention conducted by Aetna over a 3-year period to target network clinicians who prescribed antibiotics to more than 50% of outpatients diagnosed as having acute bronchitis. The company sent more than 4,500 letters to clinicians from 2016 to 2019 and observed a 6% improvement in antibiotic prescribing for bronchitis over that period.
“All antibiotic use contributes to resistance, and most antibiotics in the US are given in outpatient settings—many of them inappropriately,” David Hyun, MD, director of the Pew Charitable Trusts’ antibiotic resistance project, said in a statement emailed to reporters. “Insurance companies can give providers the information they need to improve antibiotic stewardship, and the new toolkit from CDC gives them a roadmap.”
Sep 15 CDC toolkit for healthcare payers
Transatlantic AMR task force lays out new 5-year plan
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) yesterday released a draft work plan identifying actions for continued collaboration over the next 5 years.
The plan is broken down into four key areas: appropriate antimicrobial use in human and veterinary medicine; surveillance and prevention of AMR; strategies to improve financial, access, research, and development of new antimicrobials, diagnostics, and alternative therapies; and actions to improve dissemination of information. The identified actions include consultation and regular exchanges of information among the TATFAR countries on actions that could help advance progress in those four key areas.
TATFAR was established in 2009 to bring together agencies and technical experts from the United States, Canada, the European Union, Norway, and the United Kingdom to collaborate and share best practices to strengthen domestic and global practices on appropriate antimicrobial use, prevention of healthcare-associated infections, and strategies for improving the pipeline of new antimicrobial drugs.
Sep 15 TATFAR draft work plan